New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
09:25 EDTDELL, ALKS, LTM, MAT, MCK, NFLX, VVUS, GDOT, CTRP, TSN, MRK, ADNC, ELNOn The Fly: Pre-market Movers
UP AFTER EARNINGS/GUIDANCE: Audience (ADNC), up 30%... Tyson Foods (TSN), up 3.3%... (CTRP), up 8.5%... Green Dot (GDOT), up 6.5%... ALSO HIGHER: Dell (DELL), up 6% after Reuters says 'go private' deal may happen Monday... VIVUS (VVUS), up 5.7% after study published on weight loss drug improving cardiovascular disease risk factors... Netflix (NFLX), up 3.3% after Morgan Stanley raises price target on shares to $200... DOWN AFTER EARNINGS/GUIDANCE: Merck (MRK), down 2.9%... McKesson (MCK), down 2.1%... Mattel (MAT), down 1.7%... Life Time Fitness (LTM), down 16.4%... ALSO LOWER: Alkermes (ALKS), down 5.9% after Elan (ELN) to sell remaining stake, shares downgraded to Neutral at BofA Merrill Lynch.
Check below for free stories on DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 11, 2014
12:42 EDTVVUSOrexigen falls after FDA requires warnings on Contrave label
Subscribe for More Information
12:05 EDTTSNUSDA lowers forecasts for 2014, 2015 meat production
Subscribe for More Information
10:59 EDTVVUSArena competition picks up after Contrave approval, says Piper Jaffray
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:01 EDTVVUSOrexigen Contrave could have stronger launch than peers, says Wells Fargo
After the FDA approved Orexigen's (OREX) Contrave as a treatment option for chronic weight management, Wells Fargo does not believe the label included any significant surprises. The firm thinks multiple factors increase the chances that Contrave's launch will be stronger than two other weight loss drugs that were launched in recent years by VIVUS and Arena Pharmaceuticals (ARNA). The firm keeps an Outperform rating on Orexigen.
September 10, 2014
16:00 EDTMRK, NFLXOptions Update; September 10, 2014
Subscribe for More Information
10:26 EDTNFLXDiscovery CEO says likes doing deals with Netflix, Amazon
CEO David Zaslav says Comcast (CMCSA)/Time Warner Cable (TWC) deal "presents some serious issues," is talking to FCC about deal. Says will be opportunistic with international acquisitions, but "We don't feel like we need to acquire anything at this point." Says has more subscribers than ESPN with Europsport. Comments made at the Goldman Sachs Communacopia Conference.
10:00 EDTNFLXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:38 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:05 EDTTSNTyson Foods reinstated with a Buy at Goldman
Target $46.
08:34 confirms removal of hotel listings from Qunar, Marbridge Daily says
Subscribe for More Information
06:26 EDTNFLXNetflix initiated with a Neutral at SunTrust
Subscribe for More Information
06:04 EDTNFLXNetflix initiated with a Buy at Canaccord
Target $550.
September 9, 2014
12:55 EDTNFLXNetflix advances after analyst ups target to $600
Subscribe for More Information
12:46 EDTVVUSNovo Nordisk weight loss drug helped people get thinner, Bloomberg reports
Subscribe for More Information
12:28 removed products from Qunar site, GeoInvesting says
GeoInvesting tweeted that after visiting Qunar's (QUNR) website it confirmed (CTRP) has removed its hotel products from Qunar's website. Shares of Qunar are down 3% to $30.80 in midday trading.
09:36 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL KNDI NFLX YHOO TWTR TSLA C BAC FB MCD
08:22 EDTNFLXNetflix price target raised to $600 from $530 at RBC Capital
Subscribe for More Information
07:31 EDTNFLXNetflix enters online U.S. net neutrality strike, Reuters says
Subscribe for More Information
06:51 EDTALKSAlkermes management to meet with Leerink
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use